These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL. Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526 [Abstract] [Full Text] [Related]
5. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction. Björklund E, Jernberg T, Johanson P, Venge P, Dellborg M, Wallentin L, Lindahl B, ASSENT-2 and ASSENT-PLUS Study Groups. Heart; 2006 Jun; 92(6):735-40. PubMed ID: 16251228 [Abstract] [Full Text] [Related]
6. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Galvani M, Ottani F, Oltrona L, Ardissino D, Gensini GF, Maggioni AP, Mannucci PM, Mininni N, Prando MD, Tubaro M, Vernocchi A, Vecchio C, Italian Working Group on Atherosclerosis, Thrombosis, and Vascular Biology and the Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO). Circulation; 2004 Jul 13; 110(2):128-34. PubMed ID: 15197143 [Abstract] [Full Text] [Related]
7. Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention. de Winter RJ, Stroobants A, Koch KT, Bax M, Schotborgh CE, Mulder KJ, Sanders GT, van Straalen JP, Fischer J, Tijssen JG, Piek JJ. Am J Cardiol; 2004 Dec 15; 94(12):1481-5. PubMed ID: 15589000 [Abstract] [Full Text] [Related]
8. The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain. Brügger-Andersen T, Pönitz V, Kontny F, Staines H, Grundt H, Sagara M, Nilsen DW. Thromb Haemost; 2009 Sep 15; 102(3):555-63. PubMed ID: 19718477 [Abstract] [Full Text] [Related]
9. Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers. Westerhout CM, Fu Y, Lauer MS, James S, Armstrong PW, Al-Hattab E, Califf RM, Simoons ML, Wallentin L, Boersma E, GUSTO-IV ACS Trial Investigators. J Am Coll Cardiol; 2006 Sep 05; 48(5):939-47. PubMed ID: 16949483 [Abstract] [Full Text] [Related]
10. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P, Barnathan ES, Califf R, Topol EJ, Simoons ML, Wallentin L. Circulation; 2003 Jul 22; 108(3):275-81. PubMed ID: 12847065 [Abstract] [Full Text] [Related]
11. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Suzuki S, Takeishi Y, Niizeki T, Koyama Y, Kitahara T, Sasaki T, Sagara M, Kubota I. Am Heart J; 2008 Jan 22; 155(1):75-81. PubMed ID: 18082493 [Abstract] [Full Text] [Related]
12. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease. Campbell DJ, Woodward M, Chalmers JP, Colman SA, Jenkins AJ, Kemp BE, Neal BC, Patel A, MacMahon SW. Circulation; 2005 Jul 05; 112(1):110-6. PubMed ID: 15983245 [Abstract] [Full Text] [Related]
13. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Squire IB, O'Brien RJ, Demme B, Davies JE, Ng LL. Clin Sci (Lond); 2004 Sep 05; 107(3):309-16. PubMed ID: 15182235 [Abstract] [Full Text] [Related]
14. Prognostic value of the N-terminal pro-B-type natriuretic peptide in the elderly with acute myocardial infarction. Drewniak W, Snopek G, Zarukiewicz M, Borys M, Dabrowski M. Kardiol Pol; 2008 Jul 05; 66(7):750-5; discussion 756-7. PubMed ID: 18690566 [Abstract] [Full Text] [Related]
15. Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction. Matsui S, Ishii J, Kitagawa F, Kuno A, Hattori K, Ishikawa M, Okumura M, Kan S, Nakano T, Naruse H, Tanaka I, Nomura M, Hishida H, Ozaki Y. Atherosclerosis; 2010 May 05; 210(1):220-5. PubMed ID: 19945702 [Abstract] [Full Text] [Related]
16. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Rothenbacher D, Koenig W, Brenner H. Arch Intern Med; 2010 May 05; 166(22):2455-60. PubMed ID: 17159010 [Abstract] [Full Text] [Related]
17. Prognostic value of pentraxin 3 in patients with chronic heart failure. Kotooka N, Inoue T, Aoki S, Anan M, Komoda H, Node K. Int J Cardiol; 2008 Oct 30; 130(1):19-22. PubMed ID: 18045709 [Abstract] [Full Text] [Related]
18. The long-term prognostic value of multiple biomarkers following a myocardial infarction. Brügger-Andersen T, Aarsetøy H, Grundt H, Staines H, Nilsen DW. Thromb Res; 2008 Oct 30; 123(1):60-6. PubMed ID: 18387656 [Abstract] [Full Text] [Related]
19. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Manzano-Fernández S, Boronat-Garcia M, Albaladejo-Otón MD, Pastor P, Garrido IP, Pastor-Pérez FJ, Martínez-Hernández P, Valdés M, Pascual-Figal DA. Am J Cardiol; 2009 Jun 15; 103(12):1753-9. PubMed ID: 19539088 [Abstract] [Full Text] [Related]
20. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome. Narain VS, Gupta N, Sethi R, Puri A, Dwivedi SK, Saran RK, Puri VK. Indian Heart J; 2008 Jun 15; 60(6):536-42. PubMed ID: 19276492 [Abstract] [Full Text] [Related] Page: [Next] [New Search]